Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This study is to investigate the therapeutic efficacy and side effect of venetoclax,
azacytidine combined with chidamide for newly diagnosed acute monocytic leukemia patients
that are ineligible for intensive chemotherapy
Phase:
Phase 2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Collaborators:
Affiliated Hospital of Nantong University First Affiliated Hospital Bengbu Medical College Jining Medical University Northern Jiangsu Province People's Hospital Suzhou Hospital of Traditional Chinese Medicine Taizhou University The Second People's Hospital of Huai'an